Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NRXP | US
0.04
2.85%
Healthcare
Biotechnology
30/06/2024
17/10/2024
1.26
1.25
1.30
1.16
NRX Pharmaceuticals Inc. a clinical-stage pharmaceutical company develops novel therapeutics for the treatment of central nervous system disorders. Its products include ZYESAMI an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics that is in phase IIb/III clinical trials for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington Delaware.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
58.6%1 month
52.0%3 months
61.6%6 months
115.1%-
-
2.90
-0.47
1.63
-0.15
-
-
-23.26M
13.60M
13.60M
-
-
-
-
-682.61
5.82
5.99
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.47
Range1M
0.70
Range3M
1.45
Rel. volume
2.24
Price X volume
256.45K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
IMNN | IMNN | Biotechnology | 0.9787 | 14.09M | -2.12% | n/a | 37.13% |
Aytu BioScience Inc | AYTU | Biotechnology | 2.29 | 14.08M | 0.11% | n/a | 54.59% |
Cingulate Inc. Common Stock | CING | Biotechnology | 4.49 | 13.67M | 2.05% | n/a | 10.72% |
Tenax Therapeutics Inc | TENX | Biotechnology | 3.9 | 13.60M | 2.63% | n/a | 3.14% |
Apollomics Inc. Class A Ordinary Shares | APLM | Biotechnology | 0.1232 | 13.55M | -1.36% | n/a | 21.43% |
Edesa Biotech Inc | EDSA | Biotechnology | 4.1 | 13.42M | 0.74% | n/a | 1.35% |
Brainstorm Cell Therapeutics Inc | BCLI | Biotechnology | 2.43 | 12.92M | 11.47% | n/a | -27.28% |
KTRA | KTRA | Biotechnology | 0.2154 | 11.99M | -6.31% | n/a | 0.00% |
DOMH | DOMH | Biotechnology | 1.88 | 11.80M | -3.09% | n/a | 7.66% |
BioRestorative Therapies Inc | BRTX | Biotechnology | 1.6815 | 11.64M | -2.80% | n/a | 0.77% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.15 | 0.53 | Cheaper |
Ent. to Revenue | - | 4,005.99 | - |
PE Ratio | - | 40.42 | - |
Price to Book | 2.90 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 61.63 | 72.92 | Par |
Debt to Equity | -0.47 | -1.24 | Expensive |
Debt to Assets | 1.63 | 0.25 | Expensive |
Market Cap | 13.60M | 3.78B | Emerging |